InSysBio announces its participation in the 31st PAGE Meeting 2023 which is to be held at the Palexco Convention and Exhibition Centre, A Coruna, Spain on June 28-30, 2023. InSysBio team presents a poster within its frames:
Poster Session II - Methodology - Estimation Methods
Wednesday 15:35-17:00, June 28
Our latest posters: InSysBio team posters
About InSysBio
InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Edinburgh, UK (INSYSBIO UK LIMITED), Limassol, Cyprus (INSYSBIO CY Ltd) and Moscow, Russia (INSYSBIO LLC). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com
| ← | April 2018 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
| ||||||
|
2
|
3
|
4
|
5
1.
05 Apr 2018 15:33
XXV Russian National Congress “Man and Drug”
InSysBio today announced their participation at XXV Russian National Congress “Man and Drug”, to be held in Moscow, Russia, on April 9-12, 2018.
|
6
|
7
|
8
|
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
|
23
|
24
|
25
|
26
1.
26 Apr 2018 15:33
InSysBio, LLC Announces Extension of Collaboration with GSK on Quantitative Systems Pharmacology Modeling in Asthma
InSysBio LLC (www.insysbio.com) – pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development – announced today further collaboration with GSK - one of the world's leading research-based pharmaceutical and healthcare companies - to expand the previously developed QSP model of asthma.
|
27
|
28
|
29
|
|
30
| ||||||
Thank you for your message! We will get back to you shortly.
